J 58 (Lamivudine and zidovudine 150 mg / 300 mg)
Pill imprint J 58 has been identified as Lamivudine and zidovudine 150 mg / 300 mg.
Lamivudine/zidovudine is used in the treatment of hiv infection; occupational exposure; nonoccupational exposure and belongs to the drug class antiviral combinations. Risk cannot be ruled out during pregnancy. Lamivudine/zidovudine 150 mg / 300 mg is not subject to the Controlled Substances Act.
See also related documents.
- 150 mg / 300 mg
- Prescription only
hypromellose 2910 (6 mPa.s)
polyethylene glycol 400
sodium starch glycolate type A potato
More about lamivudine/zidovudine
- Other brands: Combivir
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.